查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1363069

呼吸系统疾病检测市场规模、份额和趋势分析报告：按产品、最终用途、用途、地区和细分市场预测，2023-2030 年

Respiratory Disease Testing Market Size, Share & Trends Analysis Report By Product (Imaging Tests, Respirometers, Blood Gas Tests), By End-use, By Application, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10个工作天内

价格

呼吸系统疾病检测市场的成长与趋势：

根据 Grand View Research, Inc. Masu 的最新报告，预计到 2030 年，全球呼吸系统疾病检测市场规模将达到 77.5 亿美元，2023 年至 2030 年年复合成长率为 2.8%。

该市场是由呼吸系统疾病患病患病上升所推动的。根据国际呼吸学会论坛统计，2014年全球有超过2亿人罹患慢性阻塞性肺病（COPD），2.35亿人患有气喘。此外，年度有超过5000万人患有职业性肺病。因此，不断增加的目标患者群体预计将推动成长。

采用电脑断层扫描 (CT) 等创新技术进行慢性阻塞性肺病诊断预计将推动成长。慢性阻塞性肺病急性医疗管理的另一项新技术是脉搏血氧测定法，用于门诊病人监测。呼吸道管理在 COPD 的检测和管理中发挥着重要作用。最近的创新也导致用于 COPD 治疗的非侵入性机械通气 (NIV) 的使用增加了 12.1%。随着技术的进步，数位放射线成像（X 光）和先进的携带式肺活量计的使用在呼吸系统疾病测试/诊断市场中越来越受欢迎。

呼吸系统疾病检测市场报告亮点

  • 呼吸系统疾病患病的增加和技术的快速进步是预计推动市场成长的两个关键因素。
  • 从按产品来看，由于创新技术的快速发展和采用，影像检查在2022年占据最大份额。
  • 从用途来看，由于全球患病不断上升，结核病将在 2022 年成为最大的市场。
  • 按最终用途，医院领域在 2022 年占据最大份额，由于住院人数增加和对住院治疗的偏好增加，预计在预测期内将出现增长。
  • 2022年，北美在呼吸道疾病检测市场占据主导地位。慢性阻塞性肺病、气喘呼吸道疾病的患病不断增加，对早期诊断的需求增加，以及患者对早期诊断益处的认识不断提高，这些都是促成这一优势的要素。
  • 预计亚太地区在预测期内将以最快的速度成长。这一增长归因于多种要素，包括医疗保健基础设施的改善以及患者对慢性阻塞性肺病和气喘等呼吸系统疾病新诊断技术可用性的认识提高。
  • 该市场的主要竞争主要企业包括但不限于 Becton Dickinson (Carefusion Corporation)、Koninklijke Philips NV (Respironics)、ResMed Company、Fischer & Paykel 和 Medtronic。这些公司在呼吸系统疾病诊断市场拥有成熟的产品系列，并且是市场上的强势品牌。

目录

第1章调查方法与范围

第2章执行摘要

第3章呼吸系统疾病检测市场变数、趋势与范围

  • 市场体系预测
    • 母市场预测
    • 相关/附随市场预测
  • 普及和成长预测图
  • 市场动态
    • 市场促进因素分析
    • 市场抑制因素分析
  • 呼吸系统疾病检测市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章呼吸道疾病检测：产品估算与趋势分析

  • 呼吸系统疾病检测市场：重点
  • 呼吸道疾病检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 影像检查
    • 2018年至2030年影像检查市场估计与预测
  • 呼吸检测设备
    • 2018年至2030年呼吸检测设备市场估计与预测
  • 血气测试
    • 2018年至2030年血液气体检测市场估计与预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第5章呼吸系统疾病检测：应用评估与趋势分析

  • 呼吸系统疾病检测市场：重点
  • 呼吸道疾病检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 慢性阻塞性肺病
  • 肺癌
  • 气喘
  • 结核
  • 其他的

第6章呼吸道疾病检测：最终用途估算与趋势分析

  • 呼吸系统疾病检测市场：重点
  • 呼吸道疾病检测市场：2022 年和 2030 年趋势和市场占有率分析
  • 医院
    • 2018年至2030年医院市场估计与预测
  • 医生办公室
    • 2018年至2030年医师诊所市场估计与预测
  • 临床实验室
    • 2018年至2030年临床检测市场估计与预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第7章呼吸系统疾病检测市场：区域估计与趋势分析

  • 区域展望
  • 按地区分類的呼吸系统疾病检测市场：市场要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 市场参与企业分类
    • Abbott
    • BD
    • Koninklijke Philips NV
    • ResMed
    • Fisher & Paykel Appliances Ltd
    • Medtronic
    • BIOMERIEUX
    • Carestream Health
    • SDI Diagnostics
    • Siemens Healthcare GmbH
Product Code: GVR-1-68038-807-7

Respiratory Disease Testing Market Growth & Trends:

The global respiratory disease testing market size is expected to reach USD 7.75 billion by 2030, registering a CAGR of 2.8% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The market is driven by the rising prevalence of respiratory diseases. As per Forum of International Respiratory Societies, more than 200 million people across the globe suffered from Chronic Obstructive Pulmonary Disease (COPD) and 235 million suffered from asthma in 2014. In addition, the source stated that more than 50 million people struggle with occupational lung diseases annually. Thus, constantly growing target patient population is anticipated to drive the growth.

The adoption of innovative technologies, such as Computed Tomography (CT), for COPD diagnosis is expected to drive the growth. The other new technology in acute medical management of COPD is pulse oximeter that is used for outpatient monitoring. Airway management plays a main role in testing and management of COPD. Also, with recent technological innovations, there has been a 12.1 % increase in the use of Noninvasive Mechanical Ventilation (NIV) for management of COPD. Along with technological advancements, use of digital radiography (X-ray) and advanced portable spirometers is gaining momentum in the respiratory disease testing/diagnostics market.

Respiratory Disease Testing Market Report Highlights:

  • Growing prevalence of respiratory diseases and rapid technological advancements are two of the major factors expected to propel the market growth
  • Based on products, imaging tests held the largest share in 2022 due to rapid development and adoption of innovative technologies
  • Based on application, tuberculosis was the largest market in 2022 owing to rising prevalence of the disease globally
  • Based on end-use, hospitals segment held the largest share in 2022 and is anticipated to grow over the forecast period due to an increase in hospitalization and a growing preference for hospital treatment
  • North America dominated the respiratory disease testing market in 2022. Growing prevalence of respiratory diseases such as COPD, & asthma, increasing demand for early diagnosis, and rising awareness amongst patients about the benefits of early diagnosis are responsible for the dominance
  • Asia Pacific region is expected to grow at the fastest rate during the forecast period. This growth can be attributed to various factors, such as improving healthcare infrastructure and increasing patient awareness regarding the availability of new diagnostic techniques for respiratory diseases, such as COPD & asthma
  • Some of the major players competing in this market include, but are not limited to, Becton Dickinson (Carefusion Corporation); Koninklijke Philips N.V. (Respironics); ResMed Company; Fischer & Paykel; and Medtronic. These players are strong brands in the market as they have elaborate product portfolios in respiratory disease diagnostics market

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Application
    • 1.1.3. End-use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End-use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Respiratory Disease Testing Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
  • 3.4. Respiratory Disease Testing Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic Landscape

Chapter 4. Respiratory Disease Testing: Product Estimates & Trend Analysis

  • 4.1. Respiratory Disease Testing Market: Key Takeaways
  • 4.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Imaging Tests
    • 4.3.1. Imaging tests market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Respiratory Measurement devices
    • 4.4.1. Respiratory measurement devices market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Blood Gas Test
    • 4.5.1. Blood gas test market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. Others
    • 4.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Respiratory Disease Testing: Application Estimates & Trend Analysis

  • 5.1. Respiratory Disease Testing Market: Key Takeaways
  • 5.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Chronic Obstructive Pulmonary Disease
    • 5.3.1. Chronic obstructive pulmonary disease market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Lung Cancer
    • 5.4.1. Lung cancer market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Asthma
    • 5.5.1. Asthma market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Tuberculosis
    • 5.6.1. Tuberculosis market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.7. Others
    • 5.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Respiratory Disease Testing: End-use Estimates & Trend Analysis

  • 6.1. Respiratory Disease Testing Market: Key Takeaways
  • 6.2. Respiratory Disease Testing Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Hospital
    • 6.3.1. Hospital market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Physicians Clinic
    • 6.4.1. Physician clinic market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.5. Clinical Laboratories
    • 6.5.1. Clinical laboratories market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.6. Others
    • 6.6.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Respiratory Disease Testing Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Respiratory Disease Testing Market by Region: Key Marketplace Takeaway
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Sweden
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Norway
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. Saudi Arabia
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. South Africa
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Market Participant Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic Initiatives
    • 8.2.2. BD
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Koninklijke Philips N.V.
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. ResMed
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Fisher & Paykel Appliances Ltd
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. Medtronic
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. BIOMERIEUX
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Carestream Health
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. SDI Diagnostics
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Siemens Healthcare GmbH
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviations
  • Table 2 North America respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 5 North America respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 13 Europe respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 15 Europe respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 23 France respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 24 France respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Sweden respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 32 Sweden respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 33 Sweden respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Norway respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 35 Norway respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 36 Norway respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Denmark respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 38 Denmark respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 39 Denmark respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 45 Japan respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 China respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 48 China respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 49 China respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 51 India respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 52 India respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 Thailand respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 54 Thailand respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 55 Thailand respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 South Korea respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 57 South Korea respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 58 South Korea respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Australia respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 60 Australia respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 61 Australia respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 67 Brazil respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 69 Mexico respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 70 Mexico respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Argentina respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 73 Argentina respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa respiratory disease testing market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 80 South Africa respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 UAE respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 86 UAE respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait respiratory disease testing market, by product, 2018 - 2030 (USD Million)
  • Table 89 Kuwait respiratory disease testing market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait respiratory disease testing market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Respiratory disease testing: Market outlook
  • Fig. 9 Respiratory disease testing: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Respiratory disease testing market driver impact
  • Fig. 15 Respiratory disease testing market restraint impact
  • Fig. 16 Respiratory disease testing market strategic initiatives analysis
  • Fig. 17 Respiratory disease testing market: Product movement analysis
  • Fig. 18 Respiratory disease testing market: Product outlook and key takeaways
  • Fig. 19 Imaging tests market estimates and forecasts, 2018 - 2030
  • Fig. 20 Respiratory measurement devices market estimates and forecasts, 2018 - 2030
  • Fig. 21 Blood gas test market estimates and forecasts, 2018 - 2030
  • Fig. 22 Others market estimates and forecasts, 2018 - 2030
  • Fig. 23 Respiratory disease testing market: Application movement analysis
  • Fig. 24 Respiratory disease testing market: Application outlook and key takeaways
  • Fig. 25 Chronic obstructive pulmonary disease market estimates and forecasts, 2018 - 2030
  • Fig. 26 Lung cancer market estimates and forecasts, 2018 - 2030
  • Fig. 27 Asthma market estimates and forecasts, 2018 - 2030
  • Fig. 28 Tuberculosis market estimates and forecasts, 2018 - 2030
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030
  • Fig. 30 Respiratory disease testing market: End-use movement analysis
  • Fig. 31 Respiratory disease testing market: End-use outlook and key takeaways
  • Fig. 32 Hospital market estimates and forecasts, 2018 - 2030
  • Fig. 33 Physicians clinic market estimates and forecasts, 2018 - 2030
  • Fig. 34 Clinical laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030
  • Fig. 36 Global Respiratory Disease Testing Market: Regional Movement Analysis
  • Fig. 37 Global Respiratory disease testing market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 44 France market estimates and forecasts, 2018 - 2030
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 47 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 48 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 49 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 52 China market estimates and forecasts, 2018 - 2030
  • Fig. 53 India market estimates and forecasts, 2018 - 2030
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 62 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 63 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030